🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

This is a fantastic meeting for students and trainees working in the cell death, inflammation and cancer fields

#NewsRelease – An AI-driven smartphone app developed by Vancouver Prostate Centre researcher Dr. Mads Daugaard will make affordable cell analytics accessible to scientists around the world: vchri.ca/news-releases/… Daugaard Laboratory @UBCmedicine Vancouver Coastal Health

An AI-driven smartphone app developed by Vancouver Prostate Centre researcher Dr. Mads Daugaard will make affordable cell analytics accessible to scientists around the world: vchri.ca/news-releases/… Daugaard Laboratory

Happy to announce the launch of our new venture SnapCyte Solutions Inc. that develops smartphone apps for life science research.

If you are working in a cell biology laboratory, please sign up for beta testing at SnapCyte.com

BREAKING NEWS: The 2022 #NobelPrize in Physiology or Medicine has been awarded to Svante Pääbo “for his discoveries concerning the genomes of extinct hominins and human evolution.”

Today we signed the agreement with a Canadian investor! “This investment will allow SnapCyte Solutions Inc. to introduce the SnapCyte™ app on the global market and initiate development of new product lines”, says Dr. Mads Daugaard, CEO. Read more below👇 snapcyte.com/financing-cana…

Glad to see SnapCyte in this great lineup!

Congrats to my PhD student Zakir Tahiry and the other recipients of the 2022 PCFBC grant. Zakir is characterizing the prostate cancer glycocalyx in search for new targeting opportunities.

A study led by Vancouver Prostate Centre researchers Nader Al Nakouzi & Daugaard Laboratory has uncovered a vital clue behind the recurrence of prostate cancer following anti-androgen hormone therapy: ow.ly/IVLG50Ltni4

Have a sneak-peek at our novel bi-functional PARP and HDAC inhibitor that combines two different therapeutic modalities into one single molecule. PoC in Ewing sarcoma. #CancerResearch #PARPi #EwingSarcoma #StBaldricks #VanProstateCtr #VCHResearch #UBC biorxiv.org/content/10.110…

Are you getting different cell confluence data than other lab members? With the SnapCyte™ app you get unbiased data in minutes, using your phone and lab microscope. Sign up to be a Beta Tester and first to try it below 👇 #AI #lifescience #biology snapcyte.com/beta-tester/?u…

Great opportunity!

Our spinoff company, SnapCyte has two exciting job opportunities: Marketing Coordinator (tinyurl.com/4nmhxvht) and Lab Assistant (tinyurl.com/2p8xh6ap). If interested please click the links!

We are thrilled and can’t wait to meet you at the 2023 Investor Showcase 🚀 #UBCEnterpreneurship #vancouver

Read more about our #jobopening 👇

Such an honour to be part of this phenomenal research environment. Happy anniversary VCHRI👍🥳

Getting close to launch now. Very exciting👍

Have a look at our latest publication describing the development and pre-clinical qualification of therapeutic antibodies targeting cancer-specific glycosaminoglycans (sugar molecules). nature.com/articles/s4146… VCH Research Institute Vancouver Prostate Centre VAR2 Pharmaceuticals University of British Columbia

Dr. Mads Daugaard and his team at VPC have developed a pulsed laser therapy that shows potential as an initial method for targeting and destroying cancer cells. prostatecentre.com/news/pulsed-la…